Prostate Cancer - Results from #19980

Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort - Abstract August 14, 2014

mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer - Abstract August 14, 2014

Who benefits from hypofractionated radiation therapy for clinically localized prostate cancer: Evidence from meta-analysis - Abstract August 14, 2014

The effect of therapeutic anticoagulation on overall survival in men receiving first-line docetaxel chemotherapy for metastatic castration-resistant prostate cancer - Abstract August 14, 2014

Patient demographic characteristics and disease stage as drivers of disparities in mortality in prostate cancer patients who receive care at a safety net academic medical center - Abstract August 14, 2014

The complexity of PSA interpretation in clinical practice - Abstract August 14, 2014

Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: A retrospective study regarding toxicity, biochemical outcome and quality of life - Abstract August 14, 2014

Hypofractionation in prostate cancer: Radiobiological basis and clinical appliance - Abstract August 14, 2014

[11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy - Abstract August 14, 2014

TMPRSS2-ERG fusion transcripts expression in patients referred for prostate biopsy: Combining detection in urine and needle rinse material - Abstract August 14, 2014

Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio - Abstract August 13, 2014

Multiparametric 3D in vivo ultrasound vibroelastography imaging of prostate cancer: Preliminary results - Abstract August 13, 2014

Impact of penile rehabilitation with low-dose vardenafil on recovery of erectile function in Japanese men following nerve-sparing radical prostatectomy - Abstract August 13, 2014

Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic - Abstract August 13, 2014

Oncologic outcomes at 10 years following robotic radical prostatectomy - Abstract August 13, 2014

Genetic predisposition to prostate cancer: Update and future perspectives - Abstract August 13, 2014

Risk factors for febrile neutropenia in patients receiving docetaxel chemotherapy for castration-resistant prostate cancer - Abstract August 13, 2014

Prognostic value of seminal vesicle involvement due to prostate cancer in radical prostatectomy specimens - Abstract August 13, 2014

The oncologic role of local treatment in primary metastatic prostate cancer - Abstract August 13, 2014

Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: Results from the randomised, phase 3 AFFIRM trial - Abstract August 13, 2014

Page 1000 of 1439